Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) Invested Capital (2020 - 2025)

PROCEPT BioRobotics has reported Invested Capital over the past 6 years, most recently at $417.5 million for Q4 2025.

  • Quarterly results put Invested Capital at $417.5 million for Q4 2025, down 7.98% from a year ago — trailing twelve months through Dec 2025 was $417.5 million (down 7.98% YoY), and the annual figure for FY2025 was $417.5 million, down 7.98%.
  • Invested Capital for Q4 2025 was $417.5 million at PROCEPT BioRobotics, down from $431.8 million in the prior quarter.
  • Over the last five years, Invested Capital for PRCT hit a ceiling of $453.7 million in Q4 2024 and a floor of -$206.3 million in Q2 2021.
  • Median Invested Capital over the past 5 years was $309.3 million (2024), compared with a mean of $278.4 million.
  • Biggest five-year swings in Invested Capital: skyrocketed 336.75% in 2021 and later fell 28.48% in 2023.
  • PROCEPT BioRobotics' Invested Capital stood at $317.1 million in 2021, then dropped by 21.7% to $248.3 million in 2022, then skyrocketed by 33.75% to $332.1 million in 2023, then soared by 36.62% to $453.7 million in 2024, then fell by 7.98% to $417.5 million in 2025.
  • The last three reported values for Invested Capital were $417.5 million (Q4 2025), $431.8 million (Q3 2025), and $437.3 million (Q2 2025) per Business Quant data.